Table 4.
Cox multivariate analysis of progression-free survival (PFS).
| HR (95% CI) | p-value | |
|---|---|---|
| TAFTI (cm2/m2) | ||
| Normal (< 118.82) | Reference | |
| High (> 118.82) | 3.47 (1.00–13.04) | 0.050 |
| SFI (cm2/m2) | ||
| Normal (< 82.97) | Reference | |
| High (> 82.97) | 1.51 (0.49–4.63) | 0.470 |
| BMI (kg/m2) | ||
| < 25 | Reference | |
| ≥ 25 | 0.70 (0.26–1.90) | 0.481 |
| ER (%) | ||
| Negative (0) | Reference | |
| Positive (≥ 1) | 0.33 (0.14–0.82) | 0.017 |
| Menopausal status | ||
| Pre | Reference | |
| Post | 0.36 (0.15–0.86) | 0.021 |
TAFTI Total abdominal fat index, SFI Subcutaneous fat Index, BMI Body mass index, ER Estrogen receptor.